BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 12498388)

  • 1. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion.
    Nithipatikom K; Isbell MA; Lindholm PF; Kajdacsy-Balla A; Kaul S; Campell WB
    Clin Exp Metastasis; 2002; 19(7):593-601. PubMed ID: 12498388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
    Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
    Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.
    Liu XH; Kirschenbaum A; Yao S; Stearns ME; Holland JF; Claffey K; Levine AC
    Clin Exp Metastasis; 1999; 17(8):687-94. PubMed ID: 10919714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic pathways of gallbladder mucosal prostanoids: the role of cyclooxygenase-1 and 2.
    Longo WE; Panesar N; Mazuski JE; Kaminski D
    Prostaglandins Leukot Essent Fatty Acids; 1999 Feb; 60(2):77-85. PubMed ID: 10328326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
    Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.
    Liu XH; Kirschenbaum A; Lu M; Yao S; Dosoretz A; Holland JF; Levine AC
    J Biol Chem; 2002 Dec; 277(51):50081-6. PubMed ID: 12401798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
    Rozic JG; Chakraborty C; Lala PK
    Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing profiles of prostaglandin formation inhibition between selective prostaglandin H synthase-2 inhibitors and conventional NSAIDs in inflammatory and non-inflammatory sites of the rat.
    Harada Y; Kawamura M; Hatanaka K; Saito M; Ogino M; Ohno T; Ogino K; Yang Q
    Prostaglandins Other Lipid Mediat; 1998 Apr; 55(5-6):345-58. PubMed ID: 9653772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
    Moalic S; Liagre B; Le Bail JC; Beneytout JL
    Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents.
    Longo WE; Panesar N; Mazuski J; Kaminski DL
    Prostaglandins Other Lipid Mediat; 1998 Aug; 56(5-6):325-39. PubMed ID: 9990676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of increased concentration of ovine endometrial cyclooxygenase 2 with the increase in PGE2 and PGD2 in the late luteal phase.
    Charpigny G; Reinaud P; Créminon C; Tamby JP
    J Reprod Fertil; 1999 Nov; 117(2):315-24. PubMed ID: 10690199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages.
    Matsumoto H; Naraba H; Murakami M; Kudo I; Yamaki K; Ueno A; Oh-ishi S
    Biochem Biophys Res Commun; 1997 Jan; 230(1):110-4. PubMed ID: 9020023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of non-steroidal anti-inflammatory drugs on prostaglandin E2 production by cyclooxygenase-2 from endogenous and exogenous arachidonic acid in rat peritoneal macrophages stimulated with lipopolysaccharide.
    Nakatsugi S; Sugimoto N; Furukawa M
    Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):451-7. PubMed ID: 9014225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
    Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
    J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
    Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
    Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated human dendritic cells express inducible cyclo-oxygenase and synthesize prostaglandin E2 but not prostaglandin D2.
    Fogel-Petrovic M; Long JA; Knight DA; Thompson PJ; Upham JW
    Immunol Cell Biol; 2004 Feb; 82(1):47-54. PubMed ID: 14984594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.
    Shinmura K; Tang XL; Wang Y; Xuan YT; Liu SQ; Takano H; Bhatnagar A; Bolli R
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10197-202. PubMed ID: 10963682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production.
    Sumitani K; Kamijo R; Toyoshima T; Nakanishi Y; Takizawa K; Hatori M; Nagumo M
    J Oral Pathol Med; 2001 Jan; 30(1):41-7. PubMed ID: 11140899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.